With financial resiliency efforts, budget constraints, and staffing shortages likely to continue, 2023 could be the year when the operational efficiencies that result from partial IT outsourcing is one of your best options for staying on track with the technology innovations your healthcare organization needs. What if you had more time to build stronger, strategic relationships with your C-suite colleagues and clinical stakeholders instead of managing day-to-day operations like the service desk? What if you could fill that gap in expertise so your IT team could deliver successfully on high priority, transformational IT projects? See why these new models will give you strategic advantage and dispel the myth that IT outsourcing will cost more, is disruptive and robs intellectual capital. Get research-based advice and value-based metrics for making decisions on the operational model that best fits your organization’s strategic objectives.

Read on go.beckershospitalreview.com

The Supply Chain Visibility Conference brings manufacturers, distributors, group purchasing organizations, and providers together to discuss ways to work together better to ensure product availability, improve forecasting, and better support patient care. Launched in 2019, this unique working conference provides an opportunity for dialogue and a venue for identifying and advancing best practices that improve supply chain resilience and visibility.

This year’s conference is more important than ever – a chance to leverage momentum from the pandemic to advance visibility and readiness in the healthcare supply chain. The Supply Chain Visibility Conference provides an ideal venue for discussing challenges and advancing preparedness and collaboration.

Read on hida.org

Some of the best healthcare innovation today is happening on the East Coast, from the Mid-Atlantic region up through the Northeast. Indeed, at the Mid-Atlantic Summit in Philadelphia, speakers will present on innovation they are working on and seeing around them, and how new and emerging technologies are paving their way into the market. At the Mid-Atlantic Healthcare Innovation Summit in Philadelphia, participants will hear from experts who are tracking the key policy and payment trends shaping the emerging operational landscape, and from the leaders of the pioneering patient care organizations using those trends to inform how they reshape care delivery. A not-to-be-missed event.

Read on endeavor.swoogo.com

A neoteric breakthrough in Precision Medicine has been acclaimed as the steppingstone in disease prediction and prevention strategies. This integral change in our approach to medication therapy has federal efforts in developing the ‘’Hyperindividualised’’ therapy while taking into account the genetic patterns, drug responses, lifestyle and cultural environment. The substantial research in disease treatment strategies have contributed to developing target drugs, study of novel biomarkers in disease diagnosis, regenerative medicine leading to customized therapeutic approaches. Precision Medicine will not only have an impact on targeted treatment delivery but the prospect of studying the biological complexity of disorders associated with high mortality rate and cost-efficient treatment plans.

MarketsandMarkets is delighted to announce its Precision Medicine Conference scheduled to be held on 8th - 9th February 2023 in San Diego, USA. The conference will assimilate diverse sessions on Comprehensive Overview of Precision Medicine, Novel horizons in biomarker strategies, Current Multi Omics analysis, Artificial Intelligence and Machine Learning, Gene expression Profiling in Precision Medicine, Contributions of Tissue engineering and Regenerative Medicine in target drug discovery. The event encompasses networking sessions, panel discussions, solutions, and services catering to precision medicine. The conference will constellate a full spectrum of experts, leaders, and stakeholders to share a board prospective the novel research and development in Precision Medicine. 

Read on events.marketsandmarkets.com

International Conference on Population Health Management and Patient Engagement aims to bring together leading academic scientists, researchers, and research scholars to exchange and share their experiences and research results on all aspects of Population Health Management and Patient Engagement. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Population Health Management and Patient Engagement.

Read on waset.org

The program format will provide timely data from the latest clinical trials and updates on state-of-the-art techniques through lectures, case presentations, and interactive discussions. Join your colleagues for the latest updates and practice guidelines in cardiology.

Topics to be Discussed:
Heart Failure
Valvular Heart Disease
Cardiac Arrhythmias
Ischemic Heart Disease
Adult Congenital Heart Disease
Prevention

LEARNING OBJECTIVES

-Describe the latest diagnostic and management strategies in heart failure
-Cite best practices for the management of patients with atrial fibrillation and ventricular arrhythmias
-Summarize the newer concepts of management of heart failure, cardiomyopathies, and valvular disease
-Identify recommendations for lipid and hypertension management

INTENDED AUDIENCE
This course is intended for clinical cardiologists, cardiac surgeons, family practice, general internists, physician assistants, nurse practitioners, and allied health personnel with a cardiovascular interest; however, pediatric cardiologists, radiologists, and other medical specialists will find the presentations and panel discussions valuable.

Time: 07:30 to 23:00

The Canadian Health and Wellbeing in Developmental Disabilities Conference is an interprofessional conference where health care providers and community partners connect to share educational and informative updates and practical, innovative, promising and effective practices that improve the health and wellbeing of people with developmental disabilities across the lifespan. The conference strives to achieve equity, diversity, and inclusion through recognition of intersectionality the inter-connected nature of social categorizations such as race, class, and gender as they apply to people with developmental disabilities, creating overlapping and interdependent systems of discrimination or disadvantage.

Read on healthandwellbeingindd.ca

The ASSR is a subspecialty society under the auspices of the American Society of Neuroradiology (ASNR) focusing on spine imaging and image-guide interventions. Originally founded in May 1993, the ASSR has grown to over 600 active US and international members from diverse clinical and scientific backgrounds dedicated to advanced the field of spinal disease diagnosis and therapy.

Read on theassr.org

Join us in February 2023, as SAE Media Group's 6th annual 3D Cell Culture Conference brings together industry experts from big pharma, regulatory bodies, and cutting-edge researchers to discuss the challenges and drivers of these medical technologies, through case studies of the latest innovations in 3D Cell Culture models, real world examples of clinical applications, and insights into regulatory validation and high throughput screening to give a comprehensive look into this fast growing industry. 3D Cell Culture has gained increasing momentum in the pharmaceutical industry over recent years, with the global 3D Cell Culture market predicted to reach a value of $3.48 Billion by 2028. The pharmaceutical industry globally is realising the growing potential of in vitro tissue models for drug discovery, pathology modelling and validation, safety and toxicity. 3D Cell Culture technology promises to offer increased translatability in models and reduce the costly rates of drug attrition in the discovery process -- heralding the next major advance in the discovery of pharmaceuticals. [Read on smgconferences.com](https://www.smgconferences.com/pharmaceuticals/uk/3D-Cell-Culture?utm_medium=www.3d-cellculture.com&utm_source=P-392&utm_campaign=Evvnt#tab_overview)

RNA therapeutics is a rapidly expanding industry with increasingly growing potential for immunotherapy, personalised medicines, and treatment of genetic, infectious, and chronic diseases. This is reflected with the value of the global antisense and RNA therapeutics market expected to reach USD 1.81 billion by 2025, growing at a CAGR of 7.5%. With Covid-19 rapidly accelerating the RNA landscape through massive regulatory successes, the recent advent of CRISPR, an RNA-guided gene-editing technology, as well as new strides in the delivery of messenger RNA transcribed in vitro, there has been considerable progress in the development of RNA medicines and a major expansion of the RNA-therapeutics field.

In 2023 we will see the return of SAE's RNA Therapeutics conference to a live in-person event, showcasing an update on mRNA therapeutic applications, coupled with an industry outlook of the field. We will also explore the latest trends in novel RNA therapies, including developments in AI modelling and small molecule modulation of RNA. Further topics to be examined comprise of novel RNA modalities encompassing self-amplifying RNA, saRNA, circular RNA, lnc RNA and many more.

Don't miss this unmissable opportunity to network with the pharma and biotech community of global experts in the UK and Europe; the two-day agenda offers you peer-to-peer networking with Directors of novel RNA therapies, CEOs, Senior and expert scientists, Chief Medical Officers, Senior Vice Presidents and many more.

Benefits of attending:
- Explore how mRNA leads the way in the genetic medicine space as the next generation of novel drug modalities
- Investigate the latest trends in AI drug discovery as a tool for designing novel RNA based therapeutics
- Enhance your knowledge of the latest innovations in RNA application and RNA delivery techniques with case studies from BioNTech, Neuway Pharma and Ethris GmbH
- Engage in the growing advances and development of novel RNA molecules in the treatment of chronic respiratory, neurodegenerative, and infectious diseases

Who should attend:
- Directors of novel RNA therapies
- CEOs
- Senior and expert scientists
- Chief Medical Officers
- Chief Technical Officers
- Senior Vice Presidents
- Global Heads of mRNA R and D
- Global Medical Directors
- Heads of Translational Medicine
- Director, Clinical Pharmacology
- Global Head of RNA and Targeted Therapeutics
- Clinical Science Director
- Head of Biology
- Director, Genetic Medicine
- Associate Director

Read on go.evvnt.com